Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NASDAQ:NAUT

Overview | Financials
Company Name Nautilus Biotechnology, Inc.
Symbol NAUT
Currency USD
Price 0.764
Market Cap 96,414,916
Dividend Yield 0%
52-week-range 0.66 - 3.09
Industry Biotechnology
Sector Healthcare
CEO Mr. Sujal M. Patel
Website https://www.nautilus.bio

An error occurred while fetching data.

About Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is

Related Stocks

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

3.93 USD

2seventy bio, Inc. logo

2seventy bio, Inc.

TSVT

5 USD

Immatics N.V. logo

Immatics N.V.

IMTX

6.48 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

11.55 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

12.3 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

5.32 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

15.71 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

6.42 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

20.95 USD

Financials

Numbers are in millions USD

Numbers are in millions USD